Kazuo Kitai
Kazuo Kitai publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and RNA Interference and Gene Delivery.
- World rank
- #5,647,012 of 7,710,434 ranked researchers
- Rank in Japan
- #197,305 of 383,136
- Works
- 17
- Citations
- 217
- Citations per work
- 12.8
What does Kazuo Kitai research?
Kazuo Kitai's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (16%), Immunology and Microbiology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1166.0%
- Everything else318.0%
- Health Sciences316.0%
- Medicine316.0%
- 1Molecular Biology48% of their works
- 2Radiology, Nuclear Medicine and Imaging12% of their works
- 3Immunology10% of their works
- 4Biotechnology4% of their works
- 5Microbiology4% of their works
- 6Endocrinology, Diabetes and Metabolism4% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- RNA Interference and Gene Delivery
- Immune Response and Inflammation
- Glycosylation and Glycoproteins Research
- RNA and protein synthesis mechanisms
- Antimicrobial Peptides and Activities
- Animal Disease Management and Epidemiology
Which keywords describe Kazuo Kitai's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Biopharmaceuticals, Protein Aggregation, Antibody Engineering, Fc Receptors and Pattern Recognition Receptors.
- African Swine Fever
- Ribosome
- Antimicrobial Peptides
- Cancer
- Toll-like Receptors
- Pattern Recognition Receptors
- Antibody Engineering
- Biopharmaceuticals
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Protein Aggregation
- Fc Receptors
- RNA Interference
- siRNA Delivery
- Glycans
- Host Defense
- Translation
- Foot-and-Mouth Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies132 topics
- Therapeutic Antibodies132 topics
- Glycosylation102 topics
- Biopharmaceuticals71 topic
- Protein Aggregation71 topic
- Antibody Engineering61 topic
- Fc Receptors61 topic
- Pattern Recognition Receptors51 topic
- RNA Interference51 topic
- Toll-like Receptors51 topic
- siRNA Delivery51 topic
- Cancer41 topic
- Glycans41 topic
- Antimicrobial Peptides21 topic
- Host Defense21 topic
- Ribosome21 topic
- Translation21 topic
- African Swine Fever11 topic
- Foot-and-Mouth Disease11 topic
Where does Kazuo Kitai work?
Kazuo Kitai's main affiliation in the publication record is Teijin (Japan), Japan.
How many publications and citations does Kazuo Kitai have?
OpenAlex counts 17 works and 217 citations for Kazuo Kitai, an h-index of 7, ranking #5,647,012 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kazuo Kitai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.